Pharnext S.A. buy melinda
Start price
30.11.17
/
50%
€431,000,000
Target price
30.05.18
€700,000,000
Performance (%)
-15.31%
End price
30.05.18
€365,000,000
Summary
This prediction ended on 30.05.18 with a price of €365,000,000. The prediction for Pharnext S.A. disappointed with a performance of -15.31%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Pharnext S.A. | - | - | - | - |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% | 69.888% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% | 101.814% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% | 45.300% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% | 63.763% |
Comments by melinda for this prediction
In the thread Pharnext SAS diskutieren
Biotechnologie und Medizintechnik SecteurRecherche Agenda 27/04 Ergebnisse Veröffentlichung
30/11/2017 | 10.57
Invest Securities wiederholt seine Empfehlung „buy“ und das Kursziel auf 14,3 Euro auf Pharnext, nachdem er einen neuen Meilenstein in der Phase - 3 - Studie Kreuzung PXT3003 in Krankheit CMT1A auswertet.
(Laufzeit überschritten)
Stopped prediction by melinda for Pharnext S.A.
Pharnext S.A.
Start price
Target price
Perf. (%)
€155,500,000
20.03.20
20.03.20
€250,000,000
04.11.21
04.11.21
-94.94%
05.11.21
05.11.21
Pharnext S.A.
Start price
Target price
Perf. (%)
€660,000,000
30.05.19
30.05.19
€1,000,000,000
20.03.20
20.03.20
-77.12%
20.03.20
20.03.20
Pharnext S.A.
Start price
Target price
Perf. (%)
€1,325,000,000
21.02.19
21.02.19
€2,500,000,000
30.05.19
30.05.19
-51.89%
30.05.19
30.05.19
Pharnext S.A.
Start price
Target price
Perf. (%)
€431,000,000
30.11.17
30.11.17
€700,000,000
30.05.18
30.05.18
-15.31%
30.05.18
30.05.18
Pharnext S.A.
Start price
Target price
Perf. (%)
€443,500,000
14.09.17
14.09.17
€640,000,000
02.11.17
02.11.17
9.36%
02.11.17
02.11.17
Pharnext S.A.
Start price
Target price
Perf. (%)
€443,500,000
14.09.17
14.09.17
€640,000,000
02.11.17
02.11.17
9.36%
02.11.17
02.11.17
Pharnext S.A.
Start price
Target price
Perf. (%)
€450,500,000
17.03.17
17.03.17
€545,000,000
10.05.17
10.05.17
33.74%
10.05.17
10.05.17


